Auteurs
Analysis
Allemagne
Racine
Analysis
Allemagne
Exploration
Accueil
Racine
Racine

Serveur d'exploration sur les relations entre la France et l'Australie - Analysis (Allemagne)

Index « Auteurs » - entrée « Peter Kolkhof »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Peter Kohl < Peter Kolkhof < Peter Kolominsky-Rabas  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 3.
Ident.Authors (with country if any)Title
000A55 (2016) Gerasimos Filippatos [Grèce] ; Stefan D. Anker [Allemagne] ; Michael Böhm [Allemagne] ; Mihai Gheorghiade [États-Unis] ; Lars K Ber [Danemark] ; Henry Krum [Australie] ; Aldo P. Maggioni [Italie] ; Piotr Ponikowski [Pologne] ; Adriaan A. Voors [Pays-Bas] ; Faiez Zannad [France] ; So-Young Kim [Allemagne] ; Christina Nowack [Allemagne] ; Giovanni Palombo [Royaume-Uni] ; Peter Kolkhof [Allemagne] ; Nina Kimmeskamp-Kirschbaum [Allemagne] ; Alexander Pieper [Allemagne] ; Bertram Pitt [États-Unis]A randomized controlled study of finerenone vs. eplerenone in patients with worsening chronic heart failure and diabetes mellitus and/or chronic kidney disease
001268 (2013) Bertram Pitt [États-Unis] ; Lars Kober [Danemark] ; Piotr Ponikowski [Pologne] ; Mihai Gheorghiade [États-Unis] ; Gerasimos Filippatos [Grèce] ; Henry Krum [Australie] ; Christina Nowack [Allemagne] ; Peter Kolkhof [Allemagne] ; So-Young Kim [Allemagne] ; Faiez Zannad [France]Safety and tolerability of the novel non-steroidal mineralocorticoid receptor antagonist BAY 94-8862 in patients with chronic heart failure and mild or moderate chronic kidney disease: a randomized, double-blind trial
001673 (2012) Bertram Pitt [États-Unis] ; Gerasimos Filippatos [Grèce] ; Mihai Gheorghiade [États-Unis] ; Lars Kober [Danemark] ; Henry Krum [Australie] ; Piotr Ponikowski [Pologne] ; Christina Nowack [Allemagne] ; Peter Kolkhof [Allemagne] ; So-Young Kim [Allemagne] ; Faiez Zannad [France]Rationale and design of ARTS: a randomized, double‐blind study of BAY 94‐8862 in patients with chronic heart failure and mild or moderate chronic kidney disease

List of associated KwdEn.i

Nombre de
documents		Descripteur
1Acetylsalicylic acid
1Aldosterone
1Aldosterone antagonist
1Aldosterone antagonist therapy
1Aldosterone antagonists
1Aldosterone blockers
1Angiotensin receptor blocker
1Antagonist
1Available mras
1Available steroidal mras
1Bayer
1Bayer healthcare
1Bayer healthcare pharmaceuticals
1Bayer pharma
1Biomarkers
1Blocker
1Blood pressure
1Blood samples
1Cardiac
1Cardiac function
1Cardiac intervention
1Cardiovascular
1Cardiovascular mortality
1Chronic heart failure
1Chronic kidney disease
1Clinical trial
1Concomitant diabetes mellitus
1Concomitant medications
1Consulting fees
1Conventional therapy
1Deleterious changes
1Demographic data
1Dose groups
1Egfr
1Eligible patients
1Eplerenone
1Full analysis
1Gerasimos filippatos
1Glycated haemoglobin
1Healthcare
1Healthcare resource
1Heart failure
1Heart rate
1Henry krum
1Hfref
1Hyperkalaemia
1Hypertension
1Independent experiments
1Inhibitor
1Lars kober
1Ltration rate
1Major protocol deviations
1Medical history
1Mihai gheorghiade
1Mild symptoms
1Mineralocorticoid
1Mineralocorticoid receptor
1Mineralocorticoid receptor antagonism
1Mineralocorticoid receptor antagonist
1Mineralocorticoid receptor antagonist activity
1Mineralocorticoid receptor antagonist tolerability study
1Mras
1Myocardial infarction
1Novartis pharma
1Nyha
1Nyha class
1Oestrogen receptor
1Other indications
1Outcome measures
1Pharmacokinetic analysis
1Physical examination
1Physicochemical properties
1Piotr ponikowski
1Pitt
1Placebo
1Placebo group
1Potassium
1Primary aldosteronism
1Progesterone receptor
1Randomized
1Randomized study
1Receptor
1Relative effects
1Renal
1Renal disease
1Renal effects
1Renal function
1Renal injury
1Renin inhibitor
1Sample size
1Screening visit
1Selective aldosterone blocker
1Serum creatinine
1Serum potassium
1Serum potassium concentration
1Serum potassium values
1Sparse sampling approach
1Spironolactone
1Spironolactone group
1Standard therapy

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Allemagne/Analysis

HfdIndexSelect -h $EXPLOR_AREA/Data/Allemagne/Analysis/Author.i -k "Peter Kolkhof" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Allemagne/Analysis/Author.i  \
                -Sk "Peter Kolkhof" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Allemagne/Analysis/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    Allemagne
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    Peter Kolkhof
}}
Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024